Abstract
({5-[4,6-Di(aziridin-1-yl)-1,3,5-triazin-2-yl]amino}-2,2-dimethyl-1,3-dioxan-5-yl)-methyl 2-(5-phenyl-2H-tetrazol-2-yl)acetate was synthesized and characterized. The interaction of the obtained tetrazole-containing 2-amino-4,6-di(aziridin-1-yl)-1,3,5-triazine derivative with DNA was studied by UV spectrophotometry, circular dichroism spectroscopy, and isothermal calorimetry. The values of binding constants (9.65·108 L mol−1, UV spectrophotometry; 4.08·108 L mol−1, isothermal calorimetry) of the 1,3,5-triazine derivative to DNA attests to efficient binding and formation of stable associates with the biopolymer. The addition of the tetrazole-containing 1,3,5-triazine derivative to a DNA solution has virtually no effect on the DNA melting point. The tetrazole-containing 1,3,5-triazine derivative exhibits a cytostatic effect on SK-HEP-1 human hepatic adenocarcinoma cells (half-maximal inhibitory concentration IC50 22.2 mmol L−1) and T98G human glioblastoma cells (IC50 44.9 mmol L−1).
Similar content being viewed by others
References
S. Singh, M. K. Mandal, A. Masih, A. Saha, S. K. Ghosh, H. R. Bhat, U. P. Singh, Arch. Pharm. (Weinheim), 2021, 354, 2000363; DOI: https://doi.org/10.1002/ardp.202000363.
P. Singla, V. Luxami, K. Paul, Eur. J. Med. Chem., 2015, 102, 39; DOI: https://doi.org/10.1016/j.ejmech.2015.07.037.
S. Cascioferro, B. Parrino, V. Spanò, A. Carbone, A. Montalbano, P. Barraja, P. Diana, G. Cirrincione, Eur. J. Med. Chem., 2017, 142, 523; DOI: https://doi.org/10.1016/j.ejmech.2017.09.035.
R. Kumar, A. D. Singh, J. Singh, H. Singh, R. K. Roy, A. Chaudhary, Rev. Med. Chem., 2014, 14, 72.
O. V. Mikolaichuk, V. V. Sharoyko, E. A. Popova, A. V. Protas, A. V. Fonin, L. V. Vasina, Y. A. Anufrikov, M. D. Luttsev, I. A. Nashchekina, A. M. Malkova, G. V. Tochilnikov, S. V. Ageev, K. N. Semenov, J. Mol. Liq., 2021, 343, 117630; DOI: https://doi.org/10.1016/j.molliq.2021.117630.
V. A. Filov, A. N. Stukov, L. L. Malyugina, B. A. Ivin, Exper. Oncol., 1996, 18, 84.
M. L. Gershanovich, V. A. Filov, D. G. Kotova, A. Stukov, L. N. Sokolov, B. A. Ivin, Vopr. Oncol., 1998, 44, 216.
P. Prasher, M. Sharma, A. A. A. Aljabali, G. Gupta, P. Negi, D. N. Kapoor, I. Singh, F. C. Zacconi, T. J. A. Pinto, M. W. Silva, H. A. Bakshi, D. K. Chellappan, M. M. Tambuwala, K. Dua, Drug Dev. Res., 2020, 81, 837; DOI: https://doi.org/10.1002/ddr.21704.
H. Guo, Q.-P. Diao, Curr. Top. Med. Chem., 2020, 20, 1481; DOI: https://doi.org/10.2174/1568026620666200310122741.
E. A. Popova, R. E. Trifonov, V. A. Ostrovskii, Russ. Chem. Rev., 2019, 88, 644; DOI: https://doi.org/10.1070/RCR4864.
V. A. Ostrovskii, R. E. Trifonov, E. A. Popova, Russ. Chem. Bull., 2012, 61, 768; DOI: https://doi.org/10.1007/s11172-012-0108-4.
V. A. Ostrovskii, E. A. Popova, R. E. Trifonov, in Reference Module in Chemistry, Molecular Sciences and Chemical Engineering, Elsevier, Oxford, 2022, 6, 182–232; DOI: https://doi.org/10.1016/B978-0-12-818655-8.00131-1.
R. J. Herr, Bioorg. Med. Chem. 2002, 10, 3379; DOI: https://doi.org/10.1016/S0968-0896(02)00239-0.
E. A. Popova, R. E. Trifonov, Russ. Chem. Rev., 2015, 84, 891; DOI: https://doi.org/10.1070/RCR4527.
O. V. Mikolaichuk, A. V. Protas, E. A. Popova, A. V. Mukhametshina, G. K. Ovsepyan, R. E. Trifonov, Russ. Chem. Bull., 2018, 67, 1312; DOI: https://doi.org/10.1007/s11172-018-2217-1.
E. A. Popova, O. V. Mikolaichuk, A. V. Protas, A. V. Mukhametshina, G. K. Ovsepyan, G. L. Starova, R. V. Suezov, A. V. Fonin, R. E. Trifonov, Russ. J. Gen. Chem., 2018, 88, 2354; DOI: https://doi.org/10.1134/S1070363218110178.
E. A. Popova, A. V. Protas, A. V. Mukhametshina, G. K. Ovsepyan, R. V. Suezov, A. V. Eremin, E. I. Stepchenkova, E. R. Tarakhovskaya, A. V. Fonin, G. L. Starova, O. V. Mikolaichuk, Y. B. Porozov, M. A. Gureev, R. E. Trifonov, Polyhedron, 2019, 158, 36; DOI: https://doi.org/10.1016/j.poly.2018.10.038.
J. A. Eremina, E. V. Lider, D. G. Samsonenko, L. A. Sheludyakova, A. S. Berezin, L. S. Klyushova, V. A. Ostrovskii, R. E. Trifonov, Inorg. Chim. Acta, 2019, 487, 138; DOI: https://doi.org/10.1016/j.ica.2018.12.011.
A. V. Protas, E. A. Popova, V. V. Suslonov, R. E. Trifonov, Polyhedron, 2017, 124, 131; DOI: https://doi.org/10.1016/j.poly.2016.12.032.
M. Sirajuddin, S. Ali, A. Badshah, J. Photochem. Photobiol. B Biol., 2013, 124, 1; DOI: https://doi.org/10.1016/j.jphotobiol.2013.03.013.
A. Wolfe, G. H. Shimer, T. Meehan, Biochemistry, 1987, 26, 6392; DOI: https://doi.org/10.1021/bi00394a01.
M. S. Raghu, C. B. Pradeep Kumar, M. K. Prashanth, K. Yogesh Kumar, B. S. Prathibha, G. Kanthimathi, S. A. Alissa, H. A. Alghulikah, S. M. Osman, New J. Chem., 2021, 45, 13909; DOI: https://doi.org/10.1039/d1nj02419a.
T. Topală, A. Bodoki, L. Oprean, R. Oprean, Farmacia, 2014, 62, 1049.
M. Fanelli, M. Formica, V. Fusi, L. Giorgi, M. Micheloni, P. Paoli, Coord. Chem. Rev., 2016, 310, 41; DOI: https://doi.org/10.1016/j.ccr.2015.11.004.
Y. M. Chang, C. K. M. Chen, M. H. Hou, Int. J. Mol. Sci., 2012, 13, 3394; DOI: https://doi.org/10.3390/ijms13033394.
https://www.cancerrxgene.org/compound/Cisplatin/1005/by-tissue?.
V. A. Ostrovskii, G. G. Danagulyan, O. M. Nesterova, Y. N. Pavlyukova, V. V. Tolstyakov, O. S. Zarubina, P. A. Slepukhin, Y. L. Esaulkova, A. A. Muryleva, V. V. Zarubaev, R. E. Trifonov, Chem. Heterocycl. Compd., 2021, 57, 448; DOI: https://doi.org/10.1007/s10593-021-02922-6.
I. Ya. Bershtein, Yu. L. Kaminskii, Spektrofotometricheskii analiz v organicheskoi khimii [Spectrophotometric Analysis in Organic Chemistry], Khimiya, Leningrad, 1973, 54 pp.
E. I. Pochkaeva, Y. A. Anufrikov, V. P. Faenkova, V. V. Sharoyko, N. A. Charykov, I. V. Murin, Russ. J. Gen. Chem., 2019, 89, 1731; DOI: https://doi.org/10.1134/s1070363219080309.
Author information
Authors and Affiliations
Corresponding author
Additional information
Based on materials of the All-Russian Congress on the Chemistry of Heterocyclic Compounds KOST-2021 (October 12–16, 2021, Sochi, Russia).
Published in Russian in Izvestiya Akademii Nauk. Seriya Khimicheskaya, No. 5, pp. 1050–1056, May, 2022.
The authors are grateful to resource centers (RC) of the Saint Petersburg State University: RC “Thermogravimetric and Calorimetric Investigation Methods”; RC “Methods for Analysis of Compositions of Compounds”, and RC “Magnetic Resonance Investigation Methods”.
This study was financially supported by the Ministry of Health of the Russian Federation (State Assignment on the Subject “Development and Antitumor Activity Assays of Conjugates of Non-annulated 1,3,5-Triazinyltetrazoles with Targeted Delivery Molecules to the Targets of Microenvironment Tumor Cells”).
No human or animal subjects were used in this research.
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Mikolaichuk, O.V., Sharoyko, V.V., Popova, E.A. et al. A new tetrazole-containing 2-amino-4,6-di(aziridin-1-yl)-1,3,5-triazine derivative: synthesis, interaction with DNA, and antitumor activity. Russ Chem Bull 71, 1050–1056 (2022). https://doi.org/10.1007/s11172-022-3507-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11172-022-3507-1